HEADER HORMONE 27-MAY-15 5BOQ TITLE HUMAN INSULIN WITH INTRA-CHAIN CHEMICAL CROSSLINK BETWEEN MODIFIED B24 TITLE 2 AND B29 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A, C, E, G; COMPND 4 FRAGMENT: UNP RESIDUES 90-110; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN; COMPND 8 CHAIN: B, D, F, H; COMPND 9 FRAGMENT: UNP RESIDUES 25-54; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: COVALENT CROSS-LINK BETWEEN MODIFIED B24 AND B29 SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 OTHER_DETAILS: SEQUENCE OCCURS NATURALLY; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS HORMONE, CHEMICAL CROSSLINK, B24-B29, SPECIFICITY EXPDTA X-RAY DIFFRACTION AUTHOR A.M.BRZOZOWSKI,J.P.TURKENBURG,J.JIRACEK,L.ZAKOVA REVDAT 3 10-JAN-24 5BOQ 1 LINK REVDAT 2 13-SEP-17 5BOQ 1 REMARK REVDAT 1 03-FEB-16 5BOQ 0 JRNL AUTH J.VIKOVA,M.COLLINSOVA,E.KLETVIKOVA,M.BUDESINSKY,V.KAPLAN, JRNL AUTH 2 L.ZAKOVA,V.VEVERKA,R.HEXNEROVA,R.J.AVINO,J.STRAKOVA, JRNL AUTH 3 I.SELICHAROVA,V.VANEK,D.W.WRIGHT,C.J.WATSON,J.P.TURKENBURG, JRNL AUTH 4 A.M.BRZOZOWSKI,J.JIRACEK JRNL TITL RATIONAL STEERING OF INSULIN BINDING SPECIFICITY BY JRNL TITL 2 INTRA-CHAIN CHEMICAL CROSSLINKING. JRNL REF SCI REP V. 6 19431 2016 JRNL REFN ESSN 2045-2322 JRNL PMID 26792393 JRNL DOI 10.1038/SREP19431 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0124 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 3 NUMBER OF REFLECTIONS : 18898 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 922 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 908 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 60.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.2050 REMARK 3 BIN FREE R VALUE SET COUNT : 40 REMARK 3 BIN FREE R VALUE : 0.2630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1385 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 200 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : 0.22000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.125 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.120 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.338 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1438 ; 0.019 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1270 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1959 ; 2.363 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2920 ; 1.101 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 177 ; 5.605 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 61 ;39.298 ;25.574 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 214 ;12.928 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 2 ;14.702 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 223 ; 0.117 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1634 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 324 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 726 ; 1.965 ; 1.768 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 725 ; 1.871 ; 1.762 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 894 ; 2.825 ; 2.624 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 895 ; 2.830 ; 2.630 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 712 ; 2.735 ; 2.092 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 701 ; 2.603 ; 2.065 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1049 ; 4.048 ; 3.017 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 1697 ; 6.318 ;16.219 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 1614 ; 6.071 ;15.632 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5BOQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000210275. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3.0 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XIA2, AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19860 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 41.280 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1MSO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M (NH4)2SO4, 1% (V/V) DIOXANE, PH REMARK 280 3.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 27.71900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.43250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.71900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.43250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 4800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -60.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO B 28 REMARK 465 NLE B 29 REMARK 465 THR B 30 REMARK 465 ASN C 21 REMARK 465 PHE D 1 REMARK 465 VAL D 2 REMARK 465 GLY D 20 REMARK 465 GLU D 21 REMARK 465 ARG D 22 REMARK 465 GLY D 23 REMARK 465 HIX D 24 REMARK 465 PHE D 25 REMARK 465 TYR D 26 REMARK 465 THR D 27 REMARK 465 PRO D 28 REMARK 465 NLE D 29 REMARK 465 THR D 30 REMARK 465 PHE F 1 REMARK 465 PHE H 1 REMARK 465 VAL H 2 REMARK 465 THR H 30 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR C 14 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN D 3 CB CG OD1 ND2 REMARK 470 TYR D 16 CD1 CD2 CE1 CE2 CZ OH REMARK 470 VAL F 2 CG1 CG2 REMARK 470 GLU F 21 CB CG CD OE1 OE2 REMARK 470 TYR G 14 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 TYR H 16 CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU H 21 CB CG CD OE1 OE2 REMARK 470 ARG H 22 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO F 28 39.09 -80.68 REMARK 500 PRO H 28 30.06 -71.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 C 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 C 102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5BPO RELATED DB: PDB REMARK 900 RELATED ID: 5BQQ RELATED DB: PDB DBREF 5BOQ A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 5BOQ B 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 5BOQ C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 5BOQ D 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 5BOQ E 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 5BOQ F 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 5BOQ G 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 5BOQ H 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 5BOQ HIX B 24 UNP P01308 PHE 48 ENGINEERED MUTATION SEQADV 5BOQ NLE B 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQADV 5BOQ HIX D 24 UNP P01308 PHE 48 ENGINEERED MUTATION SEQADV 5BOQ NLE D 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQADV 5BOQ HIX F 24 UNP P01308 PHE 48 ENGINEERED MUTATION SEQADV 5BOQ NLE F 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQADV 5BOQ HIX H 24 UNP P01308 PHE 48 ENGINEERED MUTATION SEQADV 5BOQ NLE H 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY HIX PHE TYR SEQRES 3 B 30 THR PRO NLE THR SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY HIX PHE TYR SEQRES 3 D 30 THR PRO NLE THR SEQRES 1 E 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 E 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 F 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 F 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY HIX PHE TYR SEQRES 3 F 30 THR PRO NLE THR SEQRES 1 G 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 G 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 H 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 H 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY HIX PHE TYR SEQRES 3 H 30 THR PRO NLE THR MODRES 5BOQ HIX B 24 PHE MODIFIED RESIDUE MODRES 5BOQ HIX F 24 PHE MODIFIED RESIDUE MODRES 5BOQ NLE F 29 LYS MODIFIED RESIDUE MODRES 5BOQ HIX H 24 PHE MODIFIED RESIDUE MODRES 5BOQ NLE H 29 LYS MODIFIED RESIDUE HET HIX B 24 10 HET HIX F 24 10 HET NLE F 29 8 HET HIX H 24 10 HET NLE H 29 8 HET SO4 A 101 5 HET SO4 C 101 5 HET SO4 C 102 5 HETNAM HIX 3-(1H-1,2,3-TRIAZOL-5-YL)-L-ALANINE HETNAM NLE NORLEUCINE HETNAM SO4 SULFATE ION FORMUL 2 HIX 3(C5 H8 N4 O2) FORMUL 6 NLE 2(C6 H13 N O2) FORMUL 9 SO4 3(O4 S 2-) FORMUL 12 HOH *200(H2 O) HELIX 1 AA1 GLY A 1 CYS A 7 1 7 HELIX 2 AA2 SER A 12 ASN A 18 1 7 HELIX 3 AA3 CYS B 7 GLY B 20 1 14 HELIX 4 AA4 GLU B 21 GLY B 23 5 3 HELIX 5 AA5 ILE C 2 CYS C 7 1 6 HELIX 6 AA6 SER C 12 TYR C 19 1 8 HELIX 7 AA7 GLY D 8 CYS D 19 1 12 HELIX 8 AA8 ILE E 2 CYS E 7 1 6 HELIX 9 AA9 SER E 12 ASN E 18 1 7 HELIX 10 AB1 GLY F 8 GLY F 20 1 13 HELIX 11 AB2 GLU F 21 GLY F 23 5 3 HELIX 12 AB3 ILE G 2 CYS G 7 1 6 HELIX 13 AB4 SER G 12 ASN G 18 1 7 HELIX 14 AB5 CYS H 7 GLY H 20 1 14 HELIX 15 AB6 GLU H 21 GLY H 23 5 3 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.15 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.11 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.00 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.16 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.09 SSBOND 6 CYS C 20 CYS D 19 1555 1555 1.98 SSBOND 7 CYS E 6 CYS E 11 1555 1555 2.09 SSBOND 8 CYS E 7 CYS F 7 1555 1555 2.10 SSBOND 9 CYS E 20 CYS F 19 1555 1555 2.00 SSBOND 10 CYS G 6 CYS G 11 1555 1555 2.05 SSBOND 11 CYS G 7 CYS H 7 1555 1555 2.07 SSBOND 12 CYS G 20 CYS H 19 1555 1555 2.03 LINK C GLY B 23 N HIX B 24 1555 1555 1.31 LINK C HIX B 24 N PHE B 25 1555 1555 1.33 LINK C GLY F 23 N HIX F 24 1555 1555 1.33 LINK C HIX F 24 N PHE F 25 1555 1555 1.33 LINK NE2 HIX F 24 CE NLE F 29 1555 1555 1.49 LINK C PRO F 28 N NLE F 29 1555 1555 1.32 LINK C NLE F 29 N THR F 30 1555 1555 1.35 LINK C GLY H 23 N HIX H 24 1555 1555 1.32 LINK C HIX H 24 N PHE H 25 1555 1555 1.35 LINK NE2 HIX H 24 CE NLE H 29 1555 1555 1.47 LINK C PRO H 28 N NLE H 29 1555 1555 1.35 SITE 1 AC1 10 GLU A 4 HOH A 214 HOH A 215 GLU C 4 SITE 2 AC1 10 SO4 C 101 HOH C 207 GLY E 1 GLU E 4 SITE 3 AC1 10 GLY G 1 HOH G 102 SITE 1 AC2 10 SO4 A 101 GLY C 1 ILE C 2 VAL C 3 SITE 2 AC2 10 GLU C 4 HOH C 202 HOH C 207 HOH C 211 SITE 3 AC2 10 TYR E 19 HOH G 102 SITE 1 AC3 8 TYR C 19 HOH C 203 HOH C 212 HOH C 215 SITE 2 AC3 8 GLY G 1 ILE G 2 VAL G 3 GLU G 4 CRYST1 55.438 56.865 60.012 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018038 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017586 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016663 0.00000